Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/ijms17020230 http://scihub22266oqcxt.onion/10.3390/ijms17020230 C4783962!4783962 !26875980     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26875980 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Int+J+Mol+Sci 2016 ; 17 (2 ): 230 Nephropedia Template TP {{tp|p=26875980 |t=2016. Endocannabinoids as Guardians of Metastasis |pdf=|usr=}}{{26875980 }} gab.com Text Endocannabinoids as Guardians of Metastasis JO: Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=26875980 #FOAvip Endocannabinoids including anandamide and 2-arachidonoylglycerol are involved in cancer pathophysiology in several ways, including tumor growth and progression, peritumoral inflammation, nausea and cancer pain. Recently we showed that the endocannabinoid profiles are deranged during cancer to an extent that this manifests in alterations of plasma endocannabinoids in cancer patients, which was mimicked by similar changes in rodent models of local and metastatic cancer. The present topical review summarizes the complexity of endocannabinoid signaling in the context of tumor growth and metastasis. Twit Text FOAVip Endocannabinoids as Guardians of Metastasis ????Int J Mol Sci http://www.kidney.de/pget.php?&tw=1&pmid=26875980 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26875980 #FOAvip English Wikipedia <ref>{{Cite pmid|26875980 }}</ref> Endocannabinoids as Guardians of Metastasis #MMPMID26875980 Tegeder I Int J Mol Sci 2016[Feb]; 17 (2 ): 230 PMID26875980 show ga Endocannabinoids including anandamide and 2-arachidonoylglycerol are involved in cancer pathophysiology in several ways, including tumor growth and progression, peritumoral inflammation, nausea and cancer pain. Recently we showed that the endocannabinoid profiles are deranged during cancer to an extent that this manifests in alterations of plasma endocannabinoids in cancer patients, which was mimicked by similar changes in rodent models of local and metastatic cancer. The present topical review summarizes the complexity of endocannabinoid signaling in the context of tumor growth and metastasis. |Animals [MESH] |Antineoplastic Agents/pharmacology/therapeutic use [MESH] |Arachidonic Acids/blood/metabolism [MESH] |Cannabinoids/pharmacology/therapeutic use [MESH] |Endocannabinoids/blood/*metabolism [MESH] |Ethanolamine/metabolism [MESH] |Glycerides/blood/metabolism [MESH] |Humans [MESH] |Neoplasm Metastasis [MESH] |Neoplasms/drug therapy/etiology/*metabolism/*pathology [MESH] |Oleic Acids/blood/metabolism [MESH] |Receptors, Cannabinoid/metabolism [MESH]Endocannabinoids as Guardians of Metastasis (epmc).pdf DeepDyve Pubget Overpricing